Table 3:

Association between statin use and stroke or transient ischemic attack

StatinNo. (%)OR (95% CI)Adjusted OR* (95% CI)
Cases
n = 397
Controls
n = 1588
Atorvastatin, pravastatin, fluvastatin or rosuvastatin (ref)358 (90.2)1438 (90.6)1.001.00
Simvastatin or lovastatin39 (9.8)150 (9.4)1.04 (0.72–1.51)1.33 (0.88–2.01)
  • Note: CI = confidence interval, OR = odds ratio, ref = reference category.

  • * Adjusted for history of stroke or transient ischemic attack in preceding 5 years, Charlson Comorbidity Index score, diabetes, hypertension, myocardial infarction, congestive heart failure, chronic kidney disease, number of prescription drugs in previous year, medications (β-adrenergic receptor blockers, nitrates, acetylsalicylic acid and dipyridamole, antiarrhythmics, clopidogrel, warfarin, nonsteroidal anti-inflammatory drugs, P-glycoprotein inhibitors, cytochrome P450 3A4 inhibitors), carotid Doppler ultrasonography, pacemaker insertion and duration of statin use.